global-women-health-2019-accepted-abstracts

7 / 7

Page 38
April 15-16, 2019 | Milan, Italy
OF EXCELLENCE
IN INTERNATIONAL
MEETINGS
YEARS
GlobalWomen Health 2019 Research and Reports in Gynecology and Obstetrics | ISSN: 2591-7366 | Volume 3
BREAST CANCER,
GYNECOLOGY ANDWOMEN HEALTH
2nd World Congress on
EPIDEMIOLOGICAL, CLINICAL, THERAPEUTIC AND PROGNOSTIC PROFILE OF
PATIENT WITH BREAST CANCER CONSERVING SURGERY
Othmane Elharmouchi
Ibn Sina Hospital Center, Morocco
Objective: Evaluate the conservative treatment of breast cancer performed at the Cheikha Fatma Center of the
Moroccan National Institute of Oncology and to have the epidemiological, clinical, therapeutic and prognostic
profile of the patients to whom this method of treatment has been proposed since 2013 until 2016.
Methods: Over a period of 3 years 9 months, from April 2013 to December 2016, author conducted a study of
503 breast cancer cases collected at the Cheikha Fatma Center for Gynecologic Breast Cancer at the National In-
stitute of Oncology; the aforementioned cases received conservative treatment. In this study, author evaluated
these techniques in terms of oncologic, aesthetic and prognosis aspect of the disease. Author retrospectively
assessed the overall survival without local recurrence.
Results: The median age of our patients is 47.4 years; of which 59.61% are in menopause transition with 29.2%
of nulliparous patients. Patients are classified according to the TNM classification as follows: T1: 215 cases; T2:
263 cases andT3: 17 cases. All patients received a conservative treatment with systematic standard lymph node
dissection because the sentinel lymph node technique was not performed. External radiotherapy on the re-
maining breast was always done after conservative surgery. The aesthetic results were satisfactory in all cases.
The evolution in the short and medium-term: 58 patients (11.41%) have presented a loco regional recurrence
with an average time of 11 months where as five patients have presented a bone and/or hepatic metastases
with an average time of metastatic relapse of 13.2 months.
Conclusion: The results of our study find a survival rate of 100% and a survival rate without recurrence of 81%.
References:
1. Yankaskas, B C (2006) Epidemiology of breast cancer in young women. Breast disease 23(1): 3-8.
2. Fisher B, Anderson S, Redmond C K, Wolmark N, Wickerham D L and Cronin W M (1995) Reanalysis
and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with
lumpectomy with or without irradiation in the treatment of breast cancer. New England Journal of
Medicine, 333(22):1456-1461.
3. Chung MA, SteinhoffMM, and Cady B (2002). Clinical axillary recurrence in breast cancer patients after
a negative sentinel node biopsy. The American journal of surgery, 184(4), 310-314.
4. Parmar V, Krishnamurthy A, Hawaldar R, Nadkarni M S, Sarin R, Chinoy R and Badwe R A (2006). Breast
conservation treatment in women with locally advanced breast cancer–experience from a single cen-
tre. International Journal of Surgery 4(2): 106-114.
5. Zhou P, Gautam S, and Recht A (2007). Factors affecting outcome for young women with early stage
invasive breast cancer treated with breast-conserving therapy. Breast cancer research and treatment
101(1), 51-57.
Res Rep Gynaecol Obstet 2019, Volume 3 | DOI: 10.4066/2591-7366-C2-006